Cargando…
Pathogenesis and Treatment of Myeloma-Related Bone Disease
Multiple myeloma is a hematologic malignancy of plasma cells that causes bone-destructive lesions and associated skeletal-related events (SREs). The pathogenesis of myeloma-related bone disease (MBD) is the imbalance of the bone-remodeling process, which results from osteoclast activation, osteoblas...
Autores principales: | Gau, Yuh-Ching, Yeh, Tsung-Jang, Hsu, Chin-Mu, Hsiao, Samuel Yien, Hsiao, Hui-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951013/ https://www.ncbi.nlm.nih.gov/pubmed/35328533 http://dx.doi.org/10.3390/ijms23063112 |
Ejemplares similares
-
Pathogenic Mechanisms of Myeloma Bone Disease and Possible Roles for NRF2
por: Yen, Chia-Hung, et al.
Publicado: (2020) -
Emodin Ameliorates the Efficacy of Carfilzomib in Multiple Myeloma Cells via Apoptosis and Autophagy
por: Hsu, Chin-Mu, et al.
Publicado: (2022) -
The Cost-Effectiveness Analysis of Transplant-Ineligible Myeloma Patients with Bortezomib plus Thalidomide plus Dexamethasone (VTD) or Bortezomib plus Melphalan plus Prednisolone (VMP) Treatment in Southern Taiwan
por: Du, Jeng-Shiun, et al.
Publicado: (2022) -
Management of Myeloma Bone Lesions
por: Du, Jeng-Shiun, et al.
Publicado: (2021) -
Calreticulin Mutation Survey by High Resolution Melting Method Associated with Unique Presentations in Essential Thrombocythemic Patients
por: Liu, Yi-Chang, et al.
Publicado: (2020)